Bryan C. Hanson
Chief Executive Officer
Executive
2 yr
24 reports
Solventum Corporation ·SOLV
Chief Commercial Officer centralizes all segment go-to-market
Health Care · Fortune #462 · Hybrid structure · 22K employees · Maplewood, Minnesota
View as of:
5
CEO span
↓ tighter than peers (avg 9)
3.2
Avg span
moderate
3
Max depth
3 levels
1.6 yr
Avg tenure
stable vs FY2024
0%
Internal hires
↓ below industry avg
Consolidated financials FY2025 · period end 2025-12-31 · 10-K
Revenue
$8.3B
Operating income
$2.2B
Net income
$1.6B
Total assets
$14.3B
Shares out
173M
Sourced from Solventum Corporation DEF 14A · filed 2026-03-27 ↗ View on SEC
Interactive org chart
Solventum Corporation organizational chart
Explore the executive structure, reporting layers, and scenario-ready operating model from public filings.
Open editable chart
Take this model into your AI workspace Use AI to reason through the model, then bring the scenario back into Creately Atlas.
Choose a prompt, then open an AI app and paste.
Download the CSV data instead
Solventum’s org is defined by a centralized commercial model: all operating segments and R&D report to a single Chief Commercial Officer. This page maps the executive structure, key functions, recent leadership changes, and how Solventum compares with medtech peers.
What to model
Use the chart to test org decisions, not just view reporting lines
Start with the public baseline, then use the scenario views and source-backed changes to ask what happens when leadership, span, or team ownership shifts.
Latest signal Heather Knight joined as Chief Commercial Officer
Appointed effective Nov 10, 2025 to newly created role centralizing global commercial and R&D leadership.
Source · See change logScenario views in the chart
- Add Chief AI Officer Create a Chief AI Officer reporting to the CEO to accelerate AI adoption across HIS and digital products.
- Reintroduce Segment Presidents Recreate separate MedSurg, Dental and HIS presidents reporting to the CEO to restore segment autonomy.
Atlas work this supports
- Connect Workday or UKG Get these analytics for YOUR org — tenure, span of control, headcount, automatically from your HRIS.
- Connect Salesforce Map your target accounts like this. Import contacts, visualize decision chains, plan multi-threading.
- Plan a Reorg Use this as a starting point. Model scenarios, compare structures, present options to your board.
The people
Who's running this
6 executives identified as Named Executive Officers in the most recent SEC proxy. Bar length scales with tenure.
Heather Knight
Chief Commercial Officer
Commercial
0 yr
5 reports
Wayde D. McMillan
Executive Vice President & Chief Financial Officer
Finance
2 yr
4 reports
Amy L. Landucci
Chief Information & Digital Officer
IT & Digital
2 yr
4 reports
Marcela A. Kirberger
Chief Corporate & Legal Officer
Legal
2 yr
3 reports
Chief Human Resources Officer
Chief Human Resources Officer
HR
1 yr
3 reports
The pay
Executive compensation
From the most recent DEF 14A Summary Compensation Table. 2 named executive officers disclosed. Bar length scales with total compensation.
Bryan C. Hanson $20.1M
- Base salary
- $1.35M
- Stock awards
- $15.21M
- Non-equity incentive
- $2.99M
- Other
- $592K
- Fiscal year
- FY2025
- Source
- SEC DEF 14A ↗
Wayde D. McMillan $6.2M
- Base salary
- $773K
- Stock awards
- $4.20M
- Non-equity incentive
- $1.12M
- Other
- $78K
- Fiscal year
- FY2025
- Source
- SEC DEF 14A ↗
The skin in the game
Beneficial ownership
Insider stock holdings and the company's ownership requirements for executives and directors. Disclosed in the most recent DEF 14A.
Stock ownership requirements
6×CEO base salary
5×Director cash retainer
CEO stock ownership guideline increased to 6x base salary.
The businesses
How Solventum Corporation divides the work
4 divisions report into the group CEO. Tile size scales with estimated headcount.
Medical Surgical
9K employees
Chief Commercial Officer (Heather Knight)
Advanced wound care, infection prevention and surgical solutions business.
Dental Solutions
4K employees
Chief Commercial Officer (Heather Knight)
Comprehensive dental and orthodontic products across prevention to replacement.
Health Information Systems
4K employees
Chief Commercial Officer (Heather Knight)
Healthcare software and revenue cycle management solutions.
Corporate Functions
2K employees
Chief Financial Officer (Wayde McMillan)
Finance, legal, HR, IT and enterprise services.
The thesis
Why this org is unusual
The most distinctive feature of Solventum’s structure is the concentration of all segment go-to-market and R&D authority under a single Chief Commercial Officer.
Unlike many medtech peers that retain separate segment presidents, Solventum moved MedSurg, Dental Solutions and Health Information Systems sales and R&D under Heather Knight in late 2025.
This design simplifies accountability for growth and product commercialization during the company’s post‑spin transformation. It also eliminates a layer of segment P&L leadership, leaving the CEO with a relatively tight span of five direct reports. The CFO, Legal, Digital and HR functions remain traditional enterprise centers, while commercial execution is unusually centralized for a diversified healthcare supplier.
- All segments report through a single Chief Commercial Officer
- No segment presidents or group CEOs
- Relatively tight CEO span post-spin
The comparison
How Solventum Corporation stacks up
Compared with diversified medtech peers such as Stryker, Boston Scientific and Medtronic, Solventum is more centralized in commercial leadership. Peers typically maintain segment CEOs or group presidents with full P&L control. Solventum’s approach resembles a transformation‑phase model, prioritizing speed and …
C-suite size
Reporting depth
Solventum Corporation
3 levels
5 levels
Medtronic
6 levels
5 levels
Zimmer Biomet
5 levels
Abbott
6 levels
Avg C-suite tenure
Has COO / Has CAIO
Solventum Corporation — no COO — no CAIO
Medtronic — no COO — no CAIO
Zimmer Biomet ✓ COO — no CAIO
Abbott — no COO — no CAIO
Current signals
What changed recently
Creation of a Chief Commercial Officer role in late 2025 collapsed all segment leadership under one executive.
- Date not confirmed newHeather Knight Chief Commercial Officer
Appointed effective Nov 10, 2025 to newly created role centralizing global commercial and R&D leadership.
Source - Date not confirmed departedChristopher Barry EVP & Group President, Medical Surgical
Departed effective Dec 31, 2025 following creation of the Chief Commercial Officer role.
Source - Date not confirmed departedMary Wilcox Chief Accounting Officer
Announced intent to retire and resign following successor search on Mar 20, 2026.
Source
Leadership Timeline
Year-over-year executive structure based on SEC proxy and annual filings.
FY2025
DEF 14A filed 2026-03-27
- CEO
- Bryan C. Hanson
- CEO span
- 5
- C-suite
- 5
- Avg tenure
- 1.6 yr
First full year reflecting centralized commercial leadership under a CCO.
Named executive officers (5)
- Bryan C. Hanson - Chief Executive Officer since 2023
- Wayde D. McMillan - Chief Financial Officer since 2023
- Heather Knight - Chief Commercial Officer since 2025
- Marcela A. Kirberger - Chief Corporate & Legal Officer since 2023
- Amy L. Landucci - Chief Information & Digital Officer since 2024
FY2024
DEF 14A filed 2025-03-21
- CEO
- Bryan C. Hanson
- CEO span
- 6
- C-suite
- 6
- Avg tenure
- 1.2 yr
Segment president structure still in place pre‑CCO.
Named executive officers (5)
- Bryan C. Hanson - Chief Executive Officer since 2023
- Wayde D. McMillan - Chief Financial Officer since 2023
- Marcela A. Kirberger - Chief Corporate & Legal Officer since 2023
- Amy L. Landucci - Chief Information & Digital Officer since 2024
- Christopher Barry - EVP & Group President, Medical Surgical since 2024
FY2023
10-K filed 2024-02-28
- CEO
- Bryan C. Hanson
- CEO span
- 4
- C-suite
- 4
- Avg tenure
- 0.5 yr
Initial leadership team assembled ahead of 3M separation.
Named executive officers (4)
- Bryan C. Hanson - Chief Executive Officer since 2023
- Wayde D. McMillan - Chief Financial Officer since 2023
- Marcela A. Kirberger - Chief Corporate & Legal Officer since 2023
- Amy L. Landucci - Chief Information & Digital Officer since 2024
Year-over-year changes
Solventum collapsed segment leadership into a single Chief Commercial Officer role, reducing CEO span.
- CEO span: 6 → 5
- C-suite size: 6 → 5
- Avg tenure: 1.2 → 1.6 yr
- new Heather Knight - Chief Commercial Officer (DEF 14A 2026-03-27)
- departed Christopher Barry - EVP & Group President, Medical Surgical (was EVP & Group President, Medical Surgical) (DEF 14A 2026-03-27)
Frequently Asked Questions
Who is the CEO of Solventum?
Bryan C. Hanson has served as Solventum’s Chief Executive Officer since September 2023.
What type of organizational structure does Solventum use?
Solventum uses a hybrid enterprise structure with centralized commercial leadership across all segments.
How many direct reports does Solventum's CEO have?
The CEO has five direct reports: Finance, Commercial, Legal, Digital, and HR.
How has Solventum's leadership changed recently?
In late 2025, Solventum created a Chief Commercial Officer role and eliminated the Medical Surgical group president position.
Who reports directly to Solventum's CEO?
The CEO’s direct reports are the CFO, Chief Commercial Officer, Chief Corporate & Legal Officer, Chief Information & Digital Officer, and CHRO.
Sources
- 8-K Filing, Oct 21 2025
- 8-K Filing, Mar 24 2026
- SEC EDGAR: Solventum Corporation DEF 14A Proxy Statement
- SEC EDGAR: Solventum Corporation 10-K Annual Report
Reference
Cite this page
If you reference this page in research, analysis, or news writing, use one of the formats below. Citation includes the SEC filing source where applicable.
APA 7th
Creately. (2026). Solventum Corporation organizational structure. Creately. Retrieved , from https://creately.com/org-chart/fortune-500/solventum/MLA 9th
"Solventum Corporation Organizational Structure." Creately, April 1, 2026, https://creately.com/org-chart/fortune-500/solventum/. Accessed .Chicago 17
Creately. "Solventum Corporation Organizational Structure." Last modified April 1, 2026. https://creately.com/org-chart/fortune-500/solventum/.Original SEC source View on SEC ↗
Solventum Corporation. DEF 14A. Filed 2026-03-27. U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/1964738/000196473826000017/solv-20260327.htmPermanent URL: https://creately.com/org-chart/fortune-500/solventum/ · last updated 2026-04-01